MariMed Inc.
MRMD
$0.093
-$0.002-2.11%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 6.30% | 8.47% | 10.97% | 10.97% | 10.89% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.30% | 8.47% | 10.97% | 10.97% | 10.89% |
| Cost of Revenue | 15.02% | 11.43% | 15.13% | 13.93% | 18.02% |
| Gross Profit | -4.63% | 4.75% | 5.96% | 7.43% | 3.07% |
| SG&A Expenses | 16.06% | 23.14% | 28.48% | 28.95% | 19.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.42% | 15.82% | 20.08% | 19.39% | 18.49% |
| Operating Income | -74.38% | -51.94% | -49.84% | -39.51% | -29.30% |
| Income Before Tax | 39.84% | -278.70% | -190.84% | -159.74% | -133.81% |
| Income Tax Expenses | -13.30% | -46.10% | 52.86% | 82.10% | 59.67% |
| Earnings from Continuing Operations | 24.24% | -1,163.70% | -394.98% | -291.01% | -217.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -54.17% | -3,300.00% | -58.33% | 33.78% | 83.56% |
| Net Income | 24.12% | -1,171.74% | -396.84% | -293.21% | -219.03% |
| EBIT | -74.38% | -51.94% | -49.84% | -39.51% | -29.30% |
| EBITDA | -37.77% | -22.58% | -21.65% | -15.26% | -9.18% |
| EPS Basic | 25.35% | -1,780.00% | -366.09% | -274.90% | -207.77% |
| Normalized Basic EPS | -146.39% | -95.92% | -90.64% | -82.62% | -75.51% |
| EPS Diluted | 25.35% | -1,780.00% | -366.09% | -279.12% | -216.85% |
| Normalized Diluted EPS | -146.39% | -95.74% | -89.86% | -80.87% | -72.36% |
| Average Basic Shares Outstanding | 4.37% | 6.69% | 8.77% | 9.33% | 7.58% |
| Average Diluted Shares Outstanding | 4.37% | 3.59% | 2.51% | 0.01% | -4.49% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.24% | 0.93% | -1.19% | -1.30% | -1.48% |